Mylan ($MYL) is sending its CFO, John Sheehan, on the road in Israel. That's the home country of its spurned suitor Teva ($TEVA), but it's also one place where its takeover target Perrigo ($PRGO) is publicly listed. Accoding to Reuters, Sheehan will meet with the head of the Tel Aviv Stock Exchange about listing Mylan there if it succeeds in buying the OTC drugmaker. He might also meet with some institutional investors in the country. Report